References
- Andrews CJH, Prys-Roberts C. Fentanyl – a review. Clin Anaesthesiol 1983;1:97–122
- Southam MA. Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy. Anticancer Drugs 1995;6(Suppl 3):29–34
- Peng PW, Sandler AN. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 1999;90:576–99
- Tarver SD, Stanley TH. Alternative routes of drug administration and new drug delivery systems. Adv Anesthesia 1990;7:337–67
- Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life [The TTS-Fentanyl Comparative Trial Group]. J Pain Symptom Manage 1997;13:254–61
- Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br Med J 2001;322:1154–8
- Woodroffe MA, Hays H. Fentanyl transdermal system. Pain management at home. Can Fam Phys 1997;43:268–72
- Miguel R, Kreitzer JM, Reinhart D, et al. Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial. Anesthesiology 1995;83:470–7
- Milligan K, Lanteri-Minet M, Borchert K, et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic non-cancer pain. J Pain 2001;2:197–204
- Pavelka K, Le Loet X, Bjorneboe O, et al. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control. Curr Med Res Opin 2004;20:1967–77